PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLD) (“PharmaDrug” or the “Company“), a specialty pharmaceutical company focused on the research, development...
Tryp Therapeutics announces signing of definitive agreement with Exopharm Limited. The post Tryp Therapeutics To Be Acquired by Exopharm appeared first...
Tryp Therapeutics Inc. (“Tryp” or the “Company“) (CSE:TRYP), a clinical-stage biotechnology company focused on developing intravenous-infused psilocin...
The company is targeting a listing on the Australian Securities Exchange. The post Exopharm to Buy Tryp Therapeutics in All-Stock Deal appeared first on...
The paper provides a detailed review of the pharmacological actions of ibogaine and its metabolite noribogaine, highlighting their potential in treating...
Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing...
European based biopharma MGC Pharmaceuticals has finalised a share consolidation and ~US$8 million funding as the company confidently looks towards the...
This is the first shipment that will be used specifically under the country's Authorized Prescriber Scheme enacted in July The post PharmAla Biotech ships...
PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLD) (“PharmaDrug” or the “Company“), is pleased to announce that it has closed the previously announced...
Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) (“Red Light Holland” or the “Company“), an Ontario-based corporation engaged in the...